why choose us

First received: December 08, 2022

Clinical Trial: An Observational Biomarker Study in Multiple Sclerosis (MS) Patients

Study Status: Completed

Recruit Status: RECRUITING

Condition: Multiple Sclerosis, Relapsing-Remitting

Study Type: OBSERVATIONAL


Official Title: A Multicenter Observational Study for Ex-vivo Evaluation of the Likelihood of Response to an Experimental Tolerance Restoration Therapy in Subjects Diagnosed With Multiple Sclerosis (MS)

Brief Summary: All males and females between 18-70 years of age regardless of their race and ethnicity with a confirmed diagnosis of Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), and Relapse Remitting Multiple Sclerosis (RRMS) are invited to participate in this Observational study being conducted across four sites in the US.Since this is an observational study no medication/drug or treatment will be given to the participants.The investigator will be collecting information…

Read more